<DOC>
	<DOCNO>NCT01485289</DOCNO>
	<brief_summary>The intent study complete collection clinical data subject enrol Stabilimax Dynamic Spine Stabilization IDE clinical trial ( # G060214 ) sponsor defunct Applied Spine Technologies Inc . The Applied Spine asset , include clinical trial data , acquire Rachiotek , LLC 2010 . When Applied Spine cease fund trial , number enrol patient yet complete two year follow-up visit define study endpoint clinical investigation plan . No additional patient treatment require complete study . Rachiotek interest pursue IDE approval new study information collect study essential support new Investigational Device Exemption application .</brief_summary>
	<brief_title>Stabilimax Investigational Device Exemption ( IDE ) Clinical Investigation Patient Followup Study</brief_title>
	<detailed_description />
	<mesh_term>Spinal Stenosis</mesh_term>
	<criteria>Any patient met inclusion/exclusion criterion identify Stabilimax Investigational Device Exemption study enrol Stabilimax Investigational Device Exemption study implant Stabilimax NZ control device . Any patient device remove adverse event followup report state event resolve . This apply patient formally withdraw study time .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>